What’s STIPED about?
Welcome to the website of STIPED, a new European project that aims to offer a new treatment option for children and adolescents affected by Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).
STIPED will recruit 517 children and adolescents aged from 10 to 20 years from across Europe (including Germany, France and Portugal).
The new treatment strategy developed in STIPED is based on innovative, effective and safe brain stimulation methods using transcranial direct current stimulation (tDCS), a non-invasive technique that delivers low amplitude direct currents to the brain. STIPED also introduces a completely novel concept of mental health disorders therapy based on individualization of treatment, the use of a home-based treatment device (an electrode cap), and a telemental health service enabling remote control of safety, stimulation settings, and continuous monitoring of clinical symptoms.
This project has received funding from the European Union's Horizon 2020 research and innovation programme and involves scientific collaboration between 11 universities, clinics and companies across Europe. The project runs over five years until 31st December 2021. It is coordinated by the Christian-Albrechts-University of Kiel, Germany (till end of 2018) and Evangelisches Klinikum Bethel (EvKB), Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Bielefeld (starting with January 2019).